The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
How long is long enough? Outcomes with finite-duration bispecific antibody therapy in multiple myeloma.
 
Eva Duvalyan
No Relationships to Disclose
 
Jihong Song
No Relationships to Disclose
 
Samantha Shenoy
Honoraria - Sanofi
 
Chiung-Yu Huang
No Relationships to Disclose
 
Anupama Kumar
Honoraria - AstraZeneca; Legend Biotech
Research Funding - AstraZeneca; Bristol-Myers Squibb; Celgene; Janssen
 
Jodi Lipof
Honoraria - Sanofi
Consulting or Advisory Role - AstraZeneca
Research Funding - Karyopharm Therapeutics
 
Alfred Chung
Consulting or Advisory Role - Janssen
Research Funding - Abbvie; Bristol-Myers Squibb; Caelum Biosciences; CARsgen Therapeutics; Cellectis; Janssen; K36 therapeutics; Merck
 
Jeffrey Wolf
Consulting or Advisory Role - Adaptive Biotechnologies
 
Thomas Martin
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Lilly; Pfizer
Research Funding - AMGEN (Inst); BMSi; Janssen Oncology (Inst); Sanofi (Inst)
 
Shagun Arora
No Relationships to Disclose
 
Peter Sayre
No Relationships to Disclose
 
Ajai Chari
Honoraria - Abbvie; Adaptive Biotechnologies; Amgen; Antengene; Bristol-Myers Squibb; Forus; Genentech/Roche; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Millenium Pharmaceuticals/Takeda; Sanofi
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Amgen; Antengene; Bristol-Myers Squibb; Forus; Genentech/Roche; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Millenium Pharmaceuticals/Takeda; Sanofi
Research Funding - Janssen
Travel, Accommodations, Expenses - Abbvie; Adaptive Biotechnologies; Amgen; Antengene; Bristol-Myers Squibb; Forus; Genentech/Roche; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Sanofi; Takeda/Millennium
 
Darren Pan
Honoraria - Sanofi
Consulting or Advisory Role - Johnson & Johnson; Pfizer; Regeneron